SIRT7 and prostate carcinoma: To verify their findings, using SIRT7-deficient PC3 prostate cancer cells, they demonstrated that the E-cadherin protein level was upregulated, while the mesenchymal marker vimentin and EMT-inducing transcription factor slug were both downregulated [107].